Amarin Corp PLC (AMRN)
0.6042
+0.02
(+3.58%)
USD |
NASDAQ |
Sep 27, 16:00
0.6022
0.00 (0.00%)
After-Hours: 20:00
Amarin Accounts Receivable (Quarterly): 123.69M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 123.69M |
March 31, 2024 | 115.81M |
December 31, 2023 | 133.56M |
September 30, 2023 | 122.40M |
June 30, 2023 | 122.73M |
March 31, 2023 | 133.24M |
December 31, 2022 | 130.99M |
September 30, 2022 | 123.38M |
June 30, 2022 | 143.94M |
March 31, 2022 | 110.23M |
December 31, 2021 | 163.65M |
September 30, 2021 | 149.36M |
June 30, 2021 | 182.26M |
March 31, 2021 | 151.28M |
December 31, 2020 | 154.57M |
September 30, 2020 | 147.29M |
June 30, 2020 | 124.98M |
March 31, 2020 | 158.29M |
December 31, 2019 | 116.43M |
September 30, 2019 | 103.58M |
June 30, 2019 | 95.40M |
March 31, 2019 | 79.48M |
December 31, 2018 | 66.52M |
September 30, 2018 | 47.65M |
June 30, 2018 | 50.31M |
Date | Value |
---|---|
March 31, 2018 | 39.18M |
December 31, 2017 | 45.32M |
September 30, 2017 | 34.61M |
June 30, 2017 | 37.48M |
March 31, 2017 | 29.45M |
December 31, 2016 | 19.98M |
September 30, 2016 | 17.50M |
June 30, 2016 | 17.64M |
March 31, 2016 | 15.02M |
December 31, 2015 | 13.83M |
September 30, 2015 | 11.24M |
June 30, 2015 | 9.943M |
March 31, 2015 | 8.545M |
December 31, 2014 | 7.842M |
September 30, 2014 | 6.667M |
June 30, 2014 | 6.364M |
March 31, 2014 | 4.025M |
December 31, 2013 | 3.645M |
September 30, 2013 | 3.721M |
June 30, 2013 | 2.267M |
March 31, 2013 | 3.441M |
December 31, 2012 | 0.00 |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
103.58M
Minimum
Sep 2019
182.26M
Maximum
Jun 2021
135.58M
Average
132.11M
Median
Accounts Receivable (Quarterly) Benchmarks
Trinity Biotech PLC | 17.47M |
DBV Technologies SA | -- |
Adaptimmune Therapeutics PLC | 2.335M |
Verona Pharma PLC | -- |
NuCana PLC | -- |